Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
→ read the fulll article
M&A